Product Information

CAS No.	1050477-31-0
Product Name	Finerenone

Acute Toxic

Health Hazard

Environmental Hazard

Signal Word:Danger

HCode:H301-H360-H362-H373-H410

PCode:P203-P260-P263-P264-P270-P273-P280-P301+P316-P318-P319-P321-P330-P391-P405-P501

Studies related to this compound and its mechanism of action

Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial.

European heart journal • Vol. 34, Issue 31 • 2013

PMID: 23713082 PMC: PMC3743070 DOI: 10.1093/eurheartj/eht187

Discovery of BAY 94-8862: a nonsteroidal antagonist of the mineralocorticoid receptor for the treatment of cardiorenal diseases.

ChemMedChem • Vol. 7, Issue 8 • 2012

PMID: 22791416 DOI: 10.1002/cmdc.201200081

Adrenaline and cyclic AMP stimulated uptake of chloride and fluid secretion by isolated salivary glands of the lone star tick.

Comparative biochemistry and physiology. C: Comparative pharmacology • Vol. 53, Issue 2 • 1976

PMID: 5239 DOI: 10.1016/0306-4492(76)90053-8

Finerenone

CAS No.	1050477-31-0
MDL No.	MFCD29047135
MF	C₂₁H₂₂N₄O₃
MW	378.40
InChI Key	BTBHLEZXCOBLCY-QGZVFWFLSA-N

CUSTOM SYNTHESIS

Pricing & Availability

Pack Size	Purity	Price	Availability	Action
-	-	On Request	On Request
Custom synthesis and bulk supply options are available upon request.

Product Information

CAS No.	1050477-31-0
Product Name	Finerenone

Acute Toxic

Health Hazard

Environmental Hazard

Signal Word:Danger

HCode:H301-H360-H362-H373-H410

PCode:P203-P260-P263-P264-P270-P273-P280-P301+P316-P318-P319-P321-P330-P391-P405-P501

Finerenone

Pricing & Availability

Product Information

Safety Information

Properties

Finerenone

Pricing & Availability

Product Information

Safety Information

Properties

Documentation

Finerenone

Pricing & Availability

Product Information

Safety Information

Properties

Related Articles

Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial.

Discovery of BAY 94-8862: a nonsteroidal antagonist of the mineralocorticoid receptor for the treatment of cardiorenal diseases.

Adrenaline and cyclic AMP stimulated uptake of chloride and fluid secretion by isolated salivary glands of the lone star tick.

Similar Products

4-(4-Cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide

4-(4-Cyano-2-methoxyphenyl)-5-ethoxy-1,4-dihydro-2,8-dimethyl-1,6-naphthyridine-3-carboxylic acid

2-Cyanoethyl 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxylate

Finerenone

Pricing & Availability

Product Information

Safety Information

Properties

Related Articles

Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial.

Discovery of BAY 94-8862: a nonsteroidal antagonist of the mineralocorticoid receptor for the treatment of cardiorenal diseases.

Adrenaline and cyclic AMP stimulated uptake of chloride and fluid secretion by isolated salivary glands of the lone star tick.

Similar Products

4-(4-Cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide

4-(4-Cyano-2-methoxyphenyl)-5-ethoxy-1,4-dihydro-2,8-dimethyl-1,6-naphthyridine-3-carboxylic acid

2-Cyanoethyl 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxylate

Documentation